Clinical Trial

Azithromycin in Atopic Dermatitis

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The study will evaluate the role of adding azithromycin to topical treatment in patients with mild to moderate atopic dermatitis
Trial Details
NCT Number NCT07713186
Lead Sponsor Cairo University
Conditions Atopic Dermatitis
Enrollment 40 participants
Start Date 2026-08-01
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-20